Ribose and Sport Performance
The Effect of Ribose on Performance and Recovery in Athletes
2 other identifiers
interventional
18
1 country
1
Brief Summary
Investigate the acute effect of ribose supplementation on performance and recovery in athletes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 2, 2012
CompletedFirst Posted
Study publicly available on registry
November 16, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedDecember 5, 2016
December 1, 2016
5 months
November 2, 2012
December 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in time to complete the third of 3 consecutive 3km time trials on bike
baseline and 1 week
Secondary Outcomes (1)
Performance on the 3 consecutive 3km time trials on bike
baseline and 1 week
Other Outcomes (2)
Fatigue perception after each of the 3 consecutive 3km time trials on bike
baseline and 1 week
Peak Vo2 consumption during each of the 3km time trials on bike
baseline and 1 week
Study Arms (2)
Ribose
EXPERIMENTALAfter each of the 3km time trial (3 in total), consumption of ribose incorporated in a sports drink.
Placebo
PLACEBO COMPARATORAfter each of the 3km time trial (3 in total), consumption of placebo incorporated in a sports drink.
Interventions
Eligibility Criteria
You may qualify if:
- Men and women
- Training volume \> 7hrs/week
- VO2 max \> 40 and 45 mg/kg/min (for women and men respectively)
- Otherwise healthy individuals
You may not qualify if:
- Pregnant or breastfeeding women
- Individuals with endocrine disorders, hypercholesterolemia, cardiovascular diseases, gut diseases, cancer, anemia, hypoglycemia
- Medication for lipids, diabetes, hypertension, inflammation, autoimmune diseases, mood disorders
- Excessive alcohol consumption (more than two drinks by day for men, one for women), smoking, drug use, supplements or natural products consumption during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
- Atrium Innovationscollaborator
Study Sites (1)
Université Laval
Québec, Quebec, G1V0A6, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benoît Lamarche, PhD
Institute on nutraceuticals and functional foods
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2012
First Posted
November 16, 2012
Study Start
August 1, 2012
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
December 5, 2016
Record last verified: 2016-12